Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
2ml Packaging Details Packaging DetailsForm: Lyophilized powder for solution (white to off-white).Strengths available:25 mg/vial75 mg/vialContainer: Type I clear glass vial with a rubber stopper and flip-off aluminum seal.Presentation: Each carton contains 1 single-dose vial.Labeling: Vial label and outer carton show drug name (Reblozyl / Luspatercept-aamt), strength, batch/lot number, expiry date, and storage conditions.Reconstitution: Supplied without diluent
Zhou Z, Ji K, Zhu X, wu X, Lin R, Xie C, et al
Additionally, Li et al
Therefore, CHAC1 drives ferroptosis via two convergent mechanisms: the direct depletion of glutathione and the indirect facilitation of mitochondrial ROS production, thereby coupling sustained metabolic activity to ferroptotic cell death under cysteine limitation
First identified in human plasma in the 1970s, this small tripeptide glycyl-L-histidyl-L-lysine, bound to a copper ion has become one of the most extensively referenced compounds in dermal and wound-healing research literature, largely because its copper-binding structure gives it a distinct mechanism from most other peptide sciences on the market
US$ 26.61
US$ 21.35
US$ 20.76
US$ 28.76
